Details for New Drug Application (NDA): 202431
✉ Email this page to a colleague
The generic ingredient in NARATRIPTAN is naratriptan hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the naratriptan hydrochloride profile page.
Summary for 202431
Tradename: | NARATRIPTAN |
Applicant: | Aurobindo Pharma Usa |
Ingredient: | naratriptan hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
Approval Date: | May 31, 2012 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 2.5MG BASE | ||||
Approval Date: | May 31, 2012 | TE: | RLD: | No |
Complete Access Available with Subscription